B. Thuerlimann - Concepedia

Author

B. Thuerlimann

International Breast Cancer Study Group

Also Known As

B Thuerlimann, B. Thuerlimann

Publications

349

Citations

H-Index

Concepts

All Affiliations

International Breast Cancer Study Group

About

B. Thuerlimann is an author at International Breast Cancer Study Group specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	159
2	Obstetrics	4	4	93
3	Pharmacology	3	3	89
4	Health Sciences	2	2	64
5	Pathology	1	1	34

B. Thuerlimann

Publications

319

Citations

H-Index

Page 1

	Year	Citations
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study Florian Strasser, Thomas A. Lutz, Micha T. Maeder, British Journal of Cancer	2008	160
BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer. H.T. Mouridsen, Anita Giobbie‐Hurder, L. Mauriac, Cancer Research Breast OncologyCancer ManagementGynecologyPharmacotherapyAdjuvant Endocrine Therapy	2009	41
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer. J.-M. Nabholtz, B. Thuerlimann, W.R. Bezwoda, PubMed Breast OncologyDocetaxel Vs MitomycinMedicineSevere ThrombocytopeniaPharmacology	1997	34
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer M. Lehnert, K. Mross, J. Schueller, British Journal of Cancer Breast OncologyPhase Ii TrialMedicinePharmacologyBreast Cancer	1998	32
Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer. Giuseppe Viale, MM Regan, Patrizia Dell’Orto, Cancer Research Breast OncologyGynecologyPharmacotherapyGynecology OncologyBig 1-98 Trial	2009	23
Randomized comparison of adjuvant tamoxifen (Tam) versus no hormonal treatment for premenopausal women with node-positive (N+), early stage breast cancer: first results of International Breast Cancer Study Group Trial 13–93 M. Colleoni, Shari Gelber, Ray Snyder, Journal of Clinical Oncology Breast OncologyCancer EpidemiologyHormonal TreatmentMedicineCancer Management	2004	19
Predictors of early recurrence in postmenopausal women with hormone receptor positive breast cancer in the BIG 1-98 trial L. Mauriac, Aparna Keshaviah, M. Debled, European Journal of Cancer Supplements Early RecurrenceBreast OncologyEndocrine-related CancerMedicineBig 1-98	2006	10

Page 1